Quantcast

Latest Pharmaceuticals policy Stories

2014-06-20 10:38:00

UEA New research published today in the journal Nature reveals an Achilles’ heel in the defensive barrier which surrounds drug-resistant bacterial cells. The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself. It means that in future, bacteria may not develop drug-resistance at all. The discovery doesn’t come a moment too soon. The World Health Organization has warned that...

2014-06-20 08:23:33

BUENA, N.J. and HAYWARD, Calif., June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its seventh abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA). The seventh ANDA submission was in connection with an existing development, supply and marketing agreement with Impax Laboratories, Inc. (NASDAQ: IPXL). The agreement designates IGI...

2014-06-20 08:23:31

SANTA BARBARA, Calif., June 20, 2014 /PRNewswire/ -- SG, LLC announced today that the firm's Alternative Investments Division has increased its investment in GENZUM by up to $20MM, with a portion of the investment reserved for additional growth capital. Dovi Frances, President of SG, LLC, will join GENZUM's board. "With a unique and scalable business model, significant partnerships with leading pharmaceutical companies, and the solid leadership of CEO Chris Achar, COO Rajin Ahuja,...

2014-06-19 09:31:10

BMJ-British Medical Journal Scrapping charges seems to have no effect on access to and take up of care England remains the only UK country still charging patients for their prescriptions – currently £8.05 (€10; $13.5) per prescribed item. Although prescription charges have been rising, the latest data show that the number of pharmaceutical items prescribed in England reached its highest level yet - over one billion in 2012 - equivalent to nearly 19 per person in that year and an...

2014-06-18 23:07:41

According to a new report from BCC Research, the global market for systemic antibiotics is expected to grow to $41.2 billion by 2018 with a compound annual growth rate (CAGR) of 0.8% between 2013 through 2018. Asian countries account for the fastest-growing market with a five-year CAGR of 1.2% due to the increasing aging population, increasing GDP rate and increasing awareness about healthcare. Wellesley, MA (PRWEB) June 18, 2014 BCC Research (http://www.bccresearch.com) reveals in its...

2014-06-18 12:36:30

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Orphan Drugs for CNS Diseases: R&D and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/therapeutic/orphan_drugs_cns_diseases_rd_market_2014_2024.html Report DetailsUncommon nerve disorders - new study explains technological and commercial prospectsWhat's the future of medicines for rare central nervous system (CNS) disorders? Visiongain's new report gives you predictions...

2014-06-18 12:33:05

SARASOTA, Fla., June 18, 2014 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that it has raised a total of $5.5 million, before fees and expenses, through a Series C Preferred stock offering from a group of accredited investors. Scarsdale Equities LLC of New York and San Francisco acted as the principal placement agent. The Company will use the proceeds to advance is novel broad-spectrum Bisphosphocin(TM) class of...

2014-06-18 12:31:39

NEW YORK, June 18, 2014 /PRNewswire/ -- U.S. News & World Report, a nationally recognized publisher of health care consumer advice and information, and Pharmacy Times, the pharmacy industry's No. 1 publication, today released the 2014 Top Recommended Health Products. The list brings the collective recommendations of thousands of pharmacists directly to consumers-covering 1,100 over-the-counter brands and more than 150 product categories....

2014-06-18 08:29:23

BAUDETTE, Minn., June 18, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has signed an exclusive license and supply agreement with Dexcel Pharma Technologies Ltd. ("Dexcel") for an ANDA drug product. Dexcel submitted the ANDA application in December 2011. Dexcel will be responsible for obtaining FDA approval and manufacturing the product, and ANI Pharmaceuticals will be responsible for marketing and distribution in the U.S. The product generates combined brand and...

2014-06-17 23:12:51

In a June 26 webinar, two national authorities on Medicare Advantage and Part D will dissect the specific implications of upcoming CMS-mandated changes and present strategies for dealing with them from both operational and financial angles. Washington, DC (PRWEB) June 17, 2014 CMS’s recent final Medicare Advantage and Part D rule imposes a number of key new requirements that will impact MA and Part D plans in 2015 and beyond. Among the changes ahead: unprecedented disclosures of pricing...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related